Cargando…
Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19
BACKGROUND: Early during the current coronavirus disease 19 (COVID-19) pandemic, hydroxychloroquine (HCQ) received a significant amount of attention as a potential antiviral treatment, such that it became one of the most commonly prescribed medications for COVID-19 patients. However, not only has th...
Autores principales: | Uzelac, Ilija, Iravanian, Shahriar, Ashikaga, Hiroshi, Bhatia, Neal K., Herndon, Conner, Kaboudian, Abouzar, Gumbart, James C., Cherry, Elizabeth M., Fenton, Flavio H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Heart Rhythm Society.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256542/ https://www.ncbi.nlm.nih.gov/pubmed/32479900 http://dx.doi.org/10.1016/j.hrthm.2020.05.030 |
Ejemplares similares
-
Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations
por: Uzelac, Ilija, et al.
Publicado: (2021) -
Real-time interactive simulations of large-scale systems on personal computers and cell phones: Toward patient-specific heart modeling and other applications
por: Kaboudian, Abouzar, et al.
Publicado: (2019) -
Theoretical Modeling and Experimental Detection of the Extracellular Phasic Impedance Modulation in Rabbit Hearts
por: Iravanian, Shahriar, et al.
Publicado: (2019) -
Methodology for Cross-Talk Elimination in Simultaneous Voltage and Calcium Optical Mapping Measurements With Semasbestic Wavelengths
por: Uzelac, Ilija, et al.
Publicado: (2022) -
Drug-induced arrhythmia: Are we cautious enough?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)